|
RVX announces first right of refusal for license deal in the US
|
4
|
Resverlogix Corp.
|
Oct 24, 2017 07:48AM
|
|
Re: Zenith Epigenetics Triple Negative Breast Cancer Clinical Data Highlighted in an Oral Discussion at the ASCO Conference
|
4
|
Zenith Epigenetics
|
Jun 22, 2022 10:40AM
|
|
Re: Additional Exempt Distribution
|
4
|
Zenith Epigenetics
|
Dec 04, 2023 09:18AM
|
|
188 Mace events?
|
4
|
Resverlogix Corp.
|
Mar 10, 2018 02:04PM
|
|
Re: NFK meeting
|
4
|
Resverlogix Corp.
|
Feb 19, 2020 04:26PM
|
|
Re: Chart indicates a return to ~$3.77 near term imo...cup or bowl pattern
|
4
|
Resverlogix Corp.
|
Sep 04, 2018 04:27PM
|
|
Re: Not acting like a company worried about the PPS.....
|
4
|
Resverlogix Corp.
|
Apr 24, 2017 06:59PM
|
|
Re: Special Meetings for RVX and Zenith are 6/30 starting at 9AM Calgary time
|
4
|
Resverlogix Corp.
|
Jun 27, 2015 02:21PM
|
|
Re: Zenith AGM
|
4
|
Zenith Epigenetics
|
Nov 22, 2023 04:23PM
|
|
Re: So what is upcoming that can hopefully affect the price,...
|
4
|
Resverlogix Corp.
|
Oct 21, 2018 11:01AM
|
|
Re: Meanwhile...back at the outhouse :-)
|
4
|
Resverlogix Corp.
|
Sep 16, 2015 11:00AM
|
|
Re: Some history
|
4
|
Resverlogix Corp.
|
Jan 24, 2023 01:27PM
|
|
Re: Some history
|
4
|
Resverlogix Corp.
|
Jan 26, 2023 09:08AM
|
|
Re: Interesting Post: Fundamentals6
|
4
|
Resverlogix Corp.
|
Oct 01, 2016 11:17AM
|
|
Re: The meeting has not been rescheduled....
|
4
|
Resverlogix Corp.
|
Aug 25, 2016 11:59AM
|
|
Re: New Publication
|
4
|
Resverlogix Corp.
|
Feb 28, 2023 04:29PM
|
|
AI and biotech drug development
|
4
|
Zenith Epigenetics
|
Sep 03, 2023 11:18AM
|
|
New article from The Life science report
|
4
|
Resverlogix Corp.
|
Sep 06, 2016 10:46AM
|
|
Re: ZEN-3694 mCRPC Trial Status
|
4
|
Zenith Epigenetics
|
Oct 24, 2017 12:04PM
|
|
Re: Any catalysts in Q1 to awaken the masses? & BLOOD!
|
4
|
Resverlogix Corp.
|
Jan 20, 2016 02:42PM
|
